Adverum Biotechnologies, Inc.

Nasdaq:ADVM

Biological Products, (No Diagnostic Substances)·REDWOOD CITY, CA

Adverum Biotechnologies, Inc. is a publicly traded clinical stage gene therapy company located in Redwood City, California.

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	4/15/25	→
10-Q	Q3 2024	9/30/24	11/4/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
↓

Earnings Releases (8-K)

22 shown

Filed	Period
8/12/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
4/15/25	Q1 FY2025	→
11/4/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
5/9/24	Q2 FY2024	→
↓

News (8-K)

58 shown

Filed	Type	Description
12/9/25	Delisting	Completion of Acquisition or Disposition of Assets	→
12/4/25	Reg FD	Regulation FD Disclosure	→
11/21/25	New Debt	Termination of a Material Definitive Agreement	→
10/24/25	Agreement	Entry into a Material Definitive Agreement	→
9/22/25	Reg FD	Regulation FD Disclosure	→
6/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
↓

Filing History(949 filings)

TypeDateAccessionPeriodSize

15-12G

Dec 19, 2025

0001193125-25-32676615-12G

—

11.4 KB

EFFECT

Dec 11, 2025

9999999995-25-003652

—

1.8 KB

EFFECT

Dec 11, 2025

9999999995-25-003651

—

1.8 KB

EFFECT

Dec 11, 2025

9999999995-25-003650

—

1.8 KB

Dec 10, 2025

0001379344-25-000006

Dec 9, 2025

38.0 KB

Dec 10, 2025

0001736315-25-000006

Dec 9, 2025

34.5 KB

Dec 10, 2025

0001814883-25-000005

Dec 9, 2025

22.6 KB

Dec 10, 2025

0001903088-25-000005

Dec 9, 2025

26.5 KB

Dec 10, 2025

0001321937-25-000005

Dec 9, 2025

23.8 KB

Dec 10, 2025

0001915254-25-000005

Dec 9, 2025

15.3 KB

Dec 10, 2025

0001298941-25-000005

Dec 9, 2025

22.2 KB

Dec 10, 2025

0001511051-25-000005

Dec 9, 2025

17.6 KB

Dec 10, 2025

0001574579-25-000004

Dec 9, 2025

20.2 KB

Dec 10, 2025

0001356950-25-000004

Dec 9, 2025

24.2 KB

Dec 10, 2025

0001636168-25-000003

Dec 9, 2025

13.1 KB

Dec 10, 2025

0001775323-25-000004

Dec 9, 2025

24.2 KB

Dec 10, 2025

0001311210-25-000004

Dec 9, 2025

32.5 KB

Dec 10, 2025

0002026299-25-000004

Dec 9, 2025

24.5 KB

SCHEDULE 13D/A

Dec 9, 2025

0001373604-25-000124

—

11.0 KB

SCHEDULE 13G/A

Dec 9, 2025

0001231919-25-000590

—

25.1 KB

Dec 9, 2025

0001231919-25-000588

Dec 9, 2025

9.8 KB

S-8 POS

Dec 9, 2025

0001193125-25-312881S-8 POS

—

44.8 KB

S-8 POS

Dec 9, 2025

0001193125-25-312877S-8 POS

—

44.8 KB

S-8 POS

Dec 9, 2025

0001193125-25-312873S-8 POS

—

44.8 KB

S-8 POS

Dec 9, 2025

0001193125-25-312869S-8 POS

—

44.8 KB

25 filings shown

Filed	Form	Description
5/23/25	DEFA14A	DEFA14A	→
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/18/25	PRE 14A	PRE 14A	→
6/11/24	DEFA14A	DEFA14A	→
5/28/24	DEFA14A	DEFA14A	→
↓

Adverum Biotechnologies, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(949 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/10/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
12/10/25	4	4	→
↓

Filed	Form	Description
12/19/25	15-12G	15-12G	→
12/11/25	EFFECT	EFFECT	→
12/11/25	EFFECT	EFFECT	→
12/11/25	EFFECT	EFFECT	→
12/9/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/9/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓